Related Experiment Videos
Should metallic vascular stents be used to treat cerebrovascular occlusive diseases?
Insights
Metallic stents have low risks but high restenosis rates in small vessels. More research is needed to define stent use in carotid artery stenosis and dural venous sinus disorders.
Area of Science:
- Interventional Neurology
- Vascular Surgery
- Medical Device Technology
Background:
- Metallic stent deployment carries minimal risks but faces challenges with intimal hyperplasia-induced restenosis, especially in smaller cerebrovascular vessels.
- The primary aim of cerebrovascular interventions is to manage symptoms and prevent stroke, with carotid endarterectomy being the preferred treatment for severe internal carotid artery stenosis.
Discussion:
- Current data on carotid angioplasty and stenting for symptomatic carotid bifurcation stenosis are insufficient for definitive recommendations.
- Stent placement presents a viable alternative for internal carotid artery dissection, potentially complementing existing surgical and anticoagulation therapies.
Key Insights:
- Restenosis due to intimal hyperplasia is a significant concern for metallic stents in small to medium-sized vessels.
- Carotid endarterectomy remains the gold standard for high-grade carotid artery stenosis.
- Stent placement shows promise as a therapeutic option for internal carotid artery dissection.
Outlook:
- Further well-designed clinical trials are crucial for establishing Level I and II evidence regarding stent efficacy in various cerebrovascular conditions.
- Investigating the role of stent placement in occlusive disorders of the dural venous sinuses warrants additional clinical studies to clarify its therapeutic potential.
Abstract:
The risks of metallic stent deployment are quite low, and the likelihood of restenosis due to intimal hyperplasia is relatively high, particularly in small to medium-size vessels. The goal of all cerebrovascular interventions is to alleviate symptoms and prevent stroke. For symptomatic carotid bifurcation stenosis, insufficient information is available regarding carotid PTA and stent placement to make any recommendations. Carotid endarterectomy is the treatment of choice in patients with a 70%-99% stenosis of the involved internal carotid artery. For internal carotid artery dissection, stent placement seems to be a reasonable therapeutic alternative that may eventually assume a position as an accepted therapeutic alternative alongside surgery and anticoagulation. The gathering of level I and level II evidence by means of well-designed clinical trials is encouraged. Similarly, the application of stent placement to occlusive disorders of the dural venous sinuses is intriguing. Additional clinical studies should help define the role of stents in these diseases.